Investor Relations

Factsheets

The Trust's monthly factsheet provides market commentary and information on current portfolio structure and investments.

Joint Lead Fund Managers, Ailsa Craig and Marek Poszepczynski provide commentary on the Trust's performance and the biotechnology sector as a whole.

The Trust's investment management team speaks to Lucy Costa Duarte on pertinent issues affecting the Trust.

September 2022 International Biotechnology Trust’s latest investor update video in which Ailsa Craig and Marek Poszepczynski, the joint lead managers of IBT, share their view on the biotech sector, M&A and the drug pricing legislation in the US Inflation Reduction Act.

March 2022 International Biotechnology Trust’s latest investor update video in which Ailsa Craig and Marek Poszepczynski, the joint lead managers of IBT, discuss the current market conditions for Biotech.

November 2021 November 2021 - a chat with Ailsa and Marek about the last six months since they took over as joint lead investment managers, how IBT has navigated the re-rating of biotech small caps, the outlook for M&A in the sector and the therapeutic areas to watch going forward.

May 2021 In this video Lucy Costa Duarte speaks to Houman Ashrafian, a Managing Partner at SV Health Investors, IBT's Fund Manager. They discuss IBT and SV's relationship, what Houman is excited about in the biotech sector and IBT's unquoted investments.

For further information about the biotechnology sector investment thesis and the Trust please refer to our investor presentation.

Please also read the disclaimer contained on the second page of the investor presentation.

Reports include information on investments, expenses, liquidity, leverage profiles and other considerations.

Annual Report Year Ended 31 August 2022 Read the Report →

Interim Report Sixth months ended 28 February 2022 Read the Report →